CAS 691868-88-9

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE

CAS: 691868-88-9

Formel: C₁₄H₅F₆N₅O

Reinheit: 90%

Farbe und Form: Solid

Molekulargewicht: 373.2128

Ref: IN-DA00G21X

2-[2,4-Bis(Trifluoromethyl)Imidazo[1,2-A]1,8-Naphthyridin-8-Yl]-1,3,4-Oxadiazole

CAS: 691868-88-9

2-[2,4-Bis(Trifluoromethyl)Imidazo[1,2-A]1,8-Naphthyridin-8-Yl]-1,3,4-Oxadiazole

Reinheit: 90%

Molekulargewicht: 373.21g/mol

Ref: 54-PC108850

RO8191

CAS: 691868-88-9

RO8191

Reinheit: ≥98%

Molekulargewicht: 373.21g/mol

Ref: 54-BUP08228

RO8191

CAS: 691868-88-9

RO8191 (CDM-3008) (CDM-3008) is an agonist of interferon (IFN) receptor.

Formel: C₁₄H₅F₆N₅O

Reinheit: 98% - 98.85%

Farbe und Form: Solid

Molekulargewicht: 373.21

Ref: TM-T22142

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE

CAS: 691868-88-9

Reinheit: 90%

Molekulargewicht: 373.2179871

Ref: 10-F863736

RO8191

CAS: 691868-88-9

RO8191 is a small molecule that has been shown to inhibit replication of hepatitis B virus (HBV) in vitro and in vivo. RO8191 has also been shown to inhibit replication of human papillomavirus (HPV) and cervical cancer cells. In cellular systems, RO8191 inhibits the activity of cellular polymerase chain reaction (PCR) replicons, which are used as a model for HBV and HPV replication. The compound also inhibits the activity of replicons derived from human immunodeficiency virus type 1 (HIV-1). In vivo, RO8191 inhibited viral load in mice infected with HBV.
Mesenchymal stromal cells (MSCs) have been shown to express high levels of RO8191's target enzyme, poly(ADP-ribose) polymerase 1 (PARP-1), suggesting that MSCs may be an effective delivery vehicle for this drug. This drug has not yet been evaluated for

Formel: C₁₄H₅F₆N₅O

Reinheit: Min. 95%

Molekulargewicht: 373.21 g/mol

Ref: 3D-RCB86888